刊名:Urologic Oncology: Seminars and Original Investigations
出版年:2017
出版时间:January 2017
年:2017
卷:35
期:1
页码:31.e13-31.e20
全文大小:1364 K
卷排序:35
文摘
About 35% of prostate cancer cases are positive for KIFC1. KIFC1 expression is an independent prognostic indicator of relapse. KIFC1 expression is associated with poor docetaxel-based therapeutic outcomes.